HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency.

Raquel Crespo, Shringar Rao, Tokameh Mahmoudi

Frontiers in cellular and infection microbiology 2022

filter terms:

HIV-1 infection remains non-curative due to the latent reservoir, primarily a small pool of resting memory CD4+ T cells bearing replication-competent provirus. Pharmacological reversal of HIV-1 latency followed by intrinsic or extrinsic cell killing has been proposed as a promising strategy to target and eliminate HIV-1 viral reservoirs. Latency reversing agents have been extensively studied for their role in reactivating HIV-1 transcription in vivo, although no permanent reduction of the viral reservoir has been observed thus far. This is partly due to the complex nature of latency, which involves strict intrinsic regulation at multiple levels at transcription and RNA processing. Still, the molecular mechanisms that control HIV-1 latency establishment and maintenance have been almost exclusively studied in the context of chromatin remodeling, transcription initiation and elongation and most known LRAs target LTR-driven transcription by manipulating these. RNA metabolism is a largely understudies but critical mechanistic step in HIV-1 gene expression and latency. In this review we provide an update on current knowledge on the role of RNA processing mechanisms in viral gene expression and latency and speculate on the possible manipulation of these pathways as a therapeutic target for future cure studies. Copyright © 2022 Crespo, Rao and Mahmoudi.

Citation

Raquel Crespo, Shringar Rao, Tokameh Mahmoudi. HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency. Frontiers in cellular and infection microbiology. 2022;12:855092